Table 2.
Neoadjuvant chemotherapy patient cohort: Clinicopathological details.
| Total Patients Analyzed | n = 114 | |
|---|---|---|
| Median age (range) | 55 years (25–76) | |
| Grade: | n = (%) | |
| 1 | 1 | (0.9%) |
| 2 | 62 | (54.4%) |
| 3 | 50 | (43.8%) |
| Unknown (at time of analysis) | 1 | (0.9%) |
| Lymph node (pre op): | n = (%) | |
| Positive | 72 | (63.2%) |
| Negative | 41 | (36.8%) |
| Surgery: | n = (%) | |
| WLE | 63 | (55.2%) |
| Mastectomy | 50 | (43.9%) |
| NA | 1 | (0.9%) |
| Subtype: | n = (%) | |
| Luminal | 57 | (49.2%) |
| Luminal HER2 | 20 | (17.7%) |
| HER2+ | 14 | (12.9%) |
| Triple negative | 23 | (20.2%) |
| Pathological complete response: | No. (%) | |
| Yes | 51 | (44.7%) |
| No | 60 | (52.6%) |
| Unknown | 3 | (2.6%) |